BRPI0417530B8 - composição para a liberação transdérmica de hormônios sem a necessidade de melhoradores de penetração, sistema terapêutico transdérmico, e kit - Google Patents
composição para a liberação transdérmica de hormônios sem a necessidade de melhoradores de penetração, sistema terapêutico transdérmico, e kitInfo
- Publication number
- BRPI0417530B8 BRPI0417530B8 BRPI0417530A BRPI0417530A BRPI0417530B8 BR PI0417530 B8 BRPI0417530 B8 BR PI0417530B8 BR PI0417530 A BRPI0417530 A BR PI0417530A BR PI0417530 A BRPI0417530 A BR PI0417530A BR PI0417530 B8 BRPI0417530 B8 BR PI0417530B8
- Authority
- BR
- Brazil
- Prior art keywords
- need
- transdermal
- penetration enhancers
- kit
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Botany (AREA)
- Reproductive Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Organic Chemistry (AREA)
- Gynecology & Obstetrics (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
Abstract
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US52871803P | 2003-12-12 | 2003-12-12 | |
US60/528,718 | 2003-12-12 | ||
EP03078881.4 | 2003-12-12 | ||
EP03078881 | 2003-12-12 | ||
PCT/IB2004/052752 WO2005058287A2 (en) | 2003-12-12 | 2004-12-10 | Transdermal delivery system of hormones without penetration enhancers |
Publications (3)
Publication Number | Publication Date |
---|---|
BRPI0417530A BRPI0417530A (pt) | 2007-03-13 |
BRPI0417530B1 BRPI0417530B1 (pt) | 2018-01-23 |
BRPI0417530B8 true BRPI0417530B8 (pt) | 2021-05-25 |
Family
ID=34702342
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0417530A BRPI0417530B8 (pt) | 2003-12-12 | 2004-12-10 | composição para a liberação transdérmica de hormônios sem a necessidade de melhoradores de penetração, sistema terapêutico transdérmico, e kit |
Country Status (15)
Country | Link |
---|---|
JP (1) | JP4965263B2 (pt) |
KR (1) | KR101168449B1 (pt) |
CN (1) | CN1913878B (pt) |
AU (1) | AU2004298930B2 (pt) |
BR (1) | BRPI0417530B8 (pt) |
CA (1) | CA2549916C (pt) |
CU (1) | CU23868B1 (pt) |
EA (1) | EA011160B1 (pt) |
EC (1) | ECSP066694A (pt) |
IL (1) | IL176112A (pt) |
MX (1) | MXPA06006682A (pt) |
NO (1) | NO341989B1 (pt) |
NZ (1) | NZ548091A (pt) |
WO (1) | WO2005058287A2 (pt) |
ZA (1) | ZA200605713B (pt) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE502004000988D1 (de) | 2003-02-21 | 2006-08-31 | Schering Ag | Uv-stabiles transdermales pflaster |
US8962013B2 (en) | 2005-05-02 | 2015-02-24 | Bayer Intellectual Property Gmbh | Multi-layered transdermal system with triazine UV absorber |
DE102005050729A1 (de) * | 2005-10-19 | 2007-04-26 | Schering Ag | Verfahren zur präventiven bedarfsweisen hormonalen Kontrazeption |
FR2900048B1 (fr) * | 2006-04-21 | 2012-11-16 | Oreal | Compositions comprenant un derive diphenyl-methane hydroxyle |
AU2015203180B2 (en) * | 2010-09-06 | 2016-06-30 | Bayer Intellectual Property Gmbh | Transdermal therapeutic systems with crystallization-inhibiting protective film (release liner) |
DE102010040299A1 (de) | 2010-09-06 | 2012-03-08 | Bayer Schering Pharma Aktiengesellschaft | Transdermale therapeutische Systeme mit kristallisationsinhibierender Schutzfolie (Release Liner) |
PT2613772T (pt) | 2010-09-06 | 2017-03-06 | Bayer Ip Gmbh | Emplastros transdérmicos de dose baixa com alta libertação de fármaco |
MX2014008693A (es) * | 2012-01-27 | 2014-08-27 | Agile Therapeutics Inc | Administracion transdermica de hormonas. |
MX2017014768A (es) * | 2015-05-18 | 2018-03-23 | Agile Therapeutics Inc | Composiciones anticonceptivas y metodos para mejorar la eficacia y modulacion de los efectos secundarios. |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE58909570D1 (de) * | 1988-10-27 | 1996-02-22 | Schering Ag | Mittel zur transdermalen applikation enthaltend gestoden |
EP0555360A1 (en) * | 1990-10-29 | 1993-08-18 | Alza Corporation | Transdermal contraceptive formulations, methods and devices |
US5512292A (en) * | 1990-10-29 | 1996-04-30 | Alza Corporation | Transdermal contraceptive formulations methods and devices |
DE4329242A1 (de) * | 1993-08-26 | 1995-03-02 | Schering Ag | Mittel zur transdermalen Applikation enthaltend Gestodenester |
DE4405898A1 (de) * | 1994-02-18 | 1995-08-24 | Schering Ag | Transdermale therapeutische Systeme enthaltend Sexualsteroide |
WO1996015776A1 (fr) * | 1994-11-18 | 1996-05-30 | Hisamitsu Pharmaceutical Co., Inc. | Timbre absorbable par voie percutanee |
UA48973C2 (uk) * | 1995-06-07 | 2002-09-16 | Орто-Макнейл Фармасьютікалз Інк. | Трансдермальний пластир на основі 17-деацетилноргестимату для попередження овуляції |
JP4346696B2 (ja) * | 1996-05-28 | 2009-10-21 | 久光製薬株式会社 | 経皮治療用装置 |
JP4167750B2 (ja) * | 1997-04-16 | 2008-10-22 | 久光製薬株式会社 | 経皮吸収用基剤及び該基剤を含有する経皮吸収製剤 |
JP4399044B2 (ja) * | 1998-10-14 | 2010-01-13 | 久光製薬株式会社 | 吸収促進剤及び該吸収促進剤を有してなる経皮吸収製剤 |
DE19906152B4 (de) * | 1999-02-10 | 2005-02-10 | Jenapharm Gmbh & Co. Kg | Wirkstoffhaltige Laminate für Transdermalsysteme |
WO2001001990A1 (fr) * | 1999-07-01 | 2001-01-11 | Hisamitsu Pharmaceutical Co., Inc. | Preparation adhesive pour absorption percutanee |
DE10053375C1 (de) * | 2000-10-27 | 2002-01-24 | Lohmann Therapie Syst Lts | Transdermale therapeutische Systeme mit lichtempfindlichen Wirkstoffen |
AU2002235155A1 (en) * | 2000-12-05 | 2002-06-18 | Noven Pharmaceuticals, Inc. | Crystallization inhibition of drugs in transdermal drug delivery systems |
-
2004
- 2004-12-10 JP JP2006543709A patent/JP4965263B2/ja active Active
- 2004-12-10 NZ NZ548091A patent/NZ548091A/en not_active IP Right Cessation
- 2004-12-10 CA CA2549916A patent/CA2549916C/en not_active Expired - Fee Related
- 2004-12-10 EA EA200601089A patent/EA011160B1/ru not_active IP Right Cessation
- 2004-12-10 AU AU2004298930A patent/AU2004298930B2/en not_active Ceased
- 2004-12-10 MX MXPA06006682A patent/MXPA06006682A/es active IP Right Grant
- 2004-12-10 KR KR1020067013923A patent/KR101168449B1/ko active IP Right Grant
- 2004-12-10 BR BRPI0417530A patent/BRPI0417530B8/pt not_active IP Right Cessation
- 2004-12-10 CN CN2004800413210A patent/CN1913878B/zh active Active
- 2004-12-10 WO PCT/IB2004/052752 patent/WO2005058287A2/en active Application Filing
-
2006
- 2006-06-05 IL IL176112A patent/IL176112A/en active IP Right Grant
- 2006-06-06 NO NO20062594A patent/NO341989B1/no not_active IP Right Cessation
- 2006-07-11 EC EC2006006694A patent/ECSP066694A/es unknown
- 2006-07-11 ZA ZA2006/05713A patent/ZA200605713B/en unknown
-
2010
- 2010-07-05 CU CU20100143A patent/CU23868B1/es active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
AU2004298930A1 (en) | 2005-06-30 |
WO2005058287A2 (en) | 2005-06-30 |
EA011160B1 (ru) | 2009-02-27 |
NO20062594L (no) | 2006-07-10 |
AU2004298930B2 (en) | 2009-11-26 |
CA2549916A1 (en) | 2005-06-30 |
JP4965263B2 (ja) | 2012-07-04 |
CU20100143A7 (es) | 2011-10-31 |
BRPI0417530B1 (pt) | 2018-01-23 |
ECSP066694A (es) | 2006-10-31 |
JP2007513938A (ja) | 2007-05-31 |
NZ548091A (en) | 2009-12-24 |
KR101168449B1 (ko) | 2012-07-25 |
IL176112A0 (en) | 2006-10-05 |
BRPI0417530A (pt) | 2007-03-13 |
CN1913878B (zh) | 2010-05-26 |
KR20060128910A (ko) | 2006-12-14 |
NO341989B1 (no) | 2018-03-12 |
EA200601089A1 (ru) | 2006-12-29 |
ZA200605713B (en) | 2008-01-08 |
WO2005058287A3 (en) | 2006-03-02 |
CU23868B1 (es) | 2013-03-27 |
CA2549916C (en) | 2013-09-17 |
CN1913878A (zh) | 2007-02-14 |
IL176112A (en) | 2011-02-28 |
MXPA06006682A (es) | 2006-08-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4863738A (en) | Skin permeation enhancer compositions using glycerol monooleate | |
MY152750A (en) | Transdermal delivery system of hormones without penetration enhancers | |
US5641504A (en) | Skin permeation enhancer compositions using glycerol monolinoleate | |
KR900005969A (ko) | 게스토덴을 함유하는 경피 투여용 제제 | |
PT836506E (pt) | Penso transdermico para administracao de 17-desacetil norgestimato so ou em combinacao com um estrogenio | |
KR890011585A (ko) | 경피식 피임약제제형 | |
KR920700602A (ko) | 폐경기후의 증후군을 치료하기 위한 경피 흡수 투여 단위 및 투여 방법 | |
IE893455L (en) | Dosage form having reduced abuse potential | |
EA026664B1 (ru) | Композиция и устройство для трансдермальной доставки прогестина | |
HUP0402213A2 (hu) | Propilénglikolmonokaprilátot tartalmazó szteroid hormontartalmú transzdermális terápiás rendszer | |
WO1992020377A1 (en) | Skin permeation enhancer compositions using glycerol monolinoleate | |
US20050287195A1 (en) | Transdermal drug delivery systems | |
BRPI0417530B8 (pt) | composição para a liberação transdérmica de hormônios sem a necessidade de melhoradores de penetração, sistema terapêutico transdérmico, e kit | |
ATE220912T1 (de) | Herstellung von st1435 enthaltenden pharmazeutischen zusammensetzungen zur topischen verwendung | |
BR0013711A (pt) | Mesoprogestinas (moduladores de receptores de progesterona) como um componente de contraceptivos femininos | |
NZ509214A (en) | Transdermal patch containing estrogen and a gestagen | |
BR0013710A (pt) | Mesoprogestinas (moduladores de receptor para progesterona) como um componente de composições para a terapia de reposição de hormÈnios (hrt) | |
KR960011233B1 (ko) | 0차 흡수속도를 갖는 지속성 경피투여 제형 및 그 제조방법 | |
DE69918124T2 (de) | Zusammensetzungen und Vorrichtungen zur transdermalen Verabreichung von Fenoldopam | |
WO2000059447A3 (fr) | Utilisation d'hormones sexuelles pour l'obtention d'une composition pharmaceutique nasale utile pour le traitement des saignements uterins indesirables | |
KR890014118A (ko) | 골다공증 치료 | |
CU20060121A7 (es) | Hormonas de administración transdérmica que no necesitan potenciadores de penetración | |
TH115856B (th) | การนำส่งฮอร์โมนผ่านผิวหนังโดยไม่ต้องการสารเพิ่มการแทรกซึม |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B15K | Others concerning applications: alteration of classification |
Free format text: PARA INT.CL: A61K 9/70, A61K 31/565, A61P 15/00 Ipc: A61K 9/70 (2011.01), A61K 31/565 (2011.01) |
|
B25D | Requested change of name of applicant approved |
Owner name: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) Free format text: NOME ALTERADO DE: SCHERING AKTIENGESELLSCHAFT |
|
B25D | Requested change of name of applicant approved |
Owner name: BAYER PHARMA AKTIENGESELLSCHAFT (DE) |
|
B25A | Requested transfer of rights approved |
Owner name: BAYER INTELLECTUAL PROPERTY GMBH. (DE) |
|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B06I | Publication of requirement cancelled [chapter 6.9 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] | ||
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 10/12/2004 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |
|
B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 18A ANUIDADE. |
|
B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2700 DE 04-10-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |